NASDAQ
ClearPoint Neuro, Inc. (CLPT) has a price/sales ratio of 10.48x as of Friday, May 22, 2026. This represents a 5.73% decrease compared to its 12-month average of 11.11x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.